Detalles de la búsqueda
1.
A bivalent porcine circovirus type 2 (PCV2), PCV2a-PCV2b, vaccine offers biologically superior protection compared to monovalent PCV2 vaccines.
Vet Res;
53(1): 12, 2022 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35180885
2.
Acceptance of oclacitinib maleate (Apoquel®) chewable tablets in client-owned dogs with allergic and atopic dermatitis.
BMC Vet Res;
18(1): 103, 2022 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35300697
3.
Speed of onset of a new chewable formulation of oclacitinib maleate (Apoquel®) in a canine model of IL-31-induced pruritus.
J Vet Pharmacol Ther;
45(4): 380-384, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35586953
4.
Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs.
BMC Vet Res;
11: 163, 2015 Jul 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-26205247
5.
A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Vet Dermatol;
26(1): 23-30, e7-8, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25496303
6.
Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life.
Vet Dermatol;
26(3): 171-9, e35, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25688708
7.
Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia.
Vet Dermatol;
25(6): 512-8, e86, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25109820
8.
Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis.
Vet Dermatol;
24(5): 479-e114, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23829933
9.
A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis.
Vet Dermatol;
24(6): 587-97, e141-2, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24581322
10.
Laboratory safety evaluation of lokivetmab, a canine anti-interleukin-31 monoclonal antibody, in dogs.
Vet Immunol Immunopathol;
258: 110574, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842258
11.
Preliminary Study on the Efficacy of a Recombinant, Subunit SARS-CoV-2 Animal Vaccine against Virulent SARS-CoV-2 Challenge in Cats.
Vaccines (Basel);
11(12)2023 Dec 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38140233
12.
Experimental veterinary SARS-CoV-2 vaccine cross neutralization of the Delta (B.1.617.2) variant virus in cats.
Vet Microbiol;
268: 109395, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35339817
13.
Field safety study of VANGUARD®crLyme: A vaccine for the prevention of Lyme disease in dogs.
Vaccine X;
6: 100080, 2020 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33336186
14.
VANGUARD®crLyme: A next generation Lyme disease vaccine that prevents B. burgdorferi infection in dogs.
Vaccine X;
6: 100079, 2020 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33336185
15.
The speed of kill of a topical combination of selamectin plus sarolaner against induced infestations of Ixodes scapularis ticks on cats.
Vet Parasitol;
270 Suppl 1: S26-S30, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30563718
16.
Comparative efficacy of topical treatments with Revolution® Plus (selamectin and sarolaner) and Bravecto® for Cats (fluralaner) against Ixodes scapularis ticks on cats.
Vet Parasitol;
270 Suppl 1: S58-S63, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31182302
17.
Efficacy of three consecutive monthly doses of a topical formulation of selamectin and sarolaner (Revolution® Plus/Stronghold® Plus) compared with a single dose of fluralaner (Bravecto® for Cats) against induced infestations of Ctenocephalides felis on cats.
Vet Parasitol;
270 Suppl 1: S52-S57, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31133494
18.
Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
Vet Parasitol;
270 Suppl 1: S3-S11, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30579753
19.
Efficacy of a topical formulation of selamectin plus sarolaner against induced infestations of Amblyomma americanum on cats and prevention of Cytauxzoon felis transmission.
Vet Parasitol;
270 Suppl 1: S31-S37, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30466895
20.
Efficacy of a new topical formulation containing selamectin plus sarolaner against three common tick species infesting cats in the United States.
Vet Parasitol;
270 Suppl 1: S19-S25, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30470637